Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine for Smoking Cessation
NCT02051309Phase 2Completed
- Sponsor
- Yale University
- Start
- Mar 2014
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nicotine dependence comparing Guanfacine with Placebo (2 arms). Primary endpoint: Rates of Prolonged Smoking Abstinence. Started Mar 2014; status: completed.
02
Drugs
guanfacine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02051309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02051309.